4 months of AGA therapy Finasterdie 1,25 EOD and Regaine
    Progress Pictures 2/26/2026

    At a glance
    In this treatment experience post, the primary subjects mentioned are
    ๐Ÿ’Š Finasteride (oral) 1.25 mg every other day 3 months
    ๐Ÿ’ง Minoxidil (Regaine) (topical) 5% twice daily
    the tone is ๐Ÿ˜ neutral with crown looks better in certain lighting results.
    A 30-year-old with Norwood 3V hair loss uses finasteride 1.25 mg every other day and Minoxidil (Regaine 5%) twice daily, experiencing no side effects with the current regimen. The front hairline remains unchanged, but the crown appears better in certain lighting.
    View this post in the Community โ†’

    Similar Community Posts Join

    6 / 1000+ results

    Related Research

    6 / 1000+ results
      Novel Agents for the Treatment of Alopecia

      research Novel Agents for the Treatment of Alopecia

      29 citations , December 1998 in “Seminars in Cutaneous Medicine and Surgery”
      New treatments for hair loss show promise, especially finasteride for men and a stronger minoxidil formula.
      Androgenetic Alopecia: Overview

      research Androgenetic Alopecia: Overview

      3 citations , November 1999 in “Journal of Cutaneous Medicine and Surgery”
      AGA is a genetic, hormonal hair loss treated with finasteride, minoxidil, and supplements, but new compounds are being developed.
      Androgenetic Alopecia in the Female

      research Androgenetic Alopecia in the Female

      82 citations , March 1994 in “Archives of Dermatology”
      2% topical minoxidil effectively treats female hair loss with minimal side effects.
      Proceedings of the Ninth World Congress for Hair Research 2015

      research Proceedings of the Ninth World Congress for Hair Research 2015

      January 2017 in “Journal of Investigative Dermatology Symposium Proceedings”
      The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.